Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery

International Journal of Antimicrobial Agents

Volumn 43, Issue 5, 2014, Pages 395-402

  Liu, Shuyuan ^a   Hou, Yinglong ^b   Chen, Xu ^c   Gao, Yuan ^a   Li, Hui ^a   Sun, Shujuan ^b  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Antifungal resistance; Combination; Fluconazole; New approaches to antifungal therapy

Indexed keywords

AMIODARONE; ANTIINFECTIVE AGENT; CALCINEURIN INHIBITOR; FLUCONAZOLE; HEAT SHOCK PROTEIN 90 INHIBITOR; HERBACEOUS AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; ANTIFUNGAL AGENT;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDIASIS; CHINESE MEDICINE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FUNGAL STRAIN; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; DRUG DEVELOPMENT; DRUG EFFECTS; DRUG INTERACTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG DISCOVERY; DRUG INTERACTIONS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS;

EID: 84899516814     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.12.009     Document Type: Short Survey

References (90)

1. J. Kriengkauykiat, J.I. Ito, and S.S. Dadwal Epidemiology and treatment approaches in management of invasive fungal infections Clin Epidemiol 3 2011 175 191
2. A. Mulu, A. Kassu, B. Anagaw, B. Moges, A. Gelaw, and M. Alemayehu et al. Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia BMC Infect Dis 13 2013 82
3. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317 (Pubitemid 39050477)
4. P.G. Pappas, B.D. Alexander, D.R. Andes, S. Hadley, C.A. Kauffman, and A. Freifeld et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 2010 1101 1111
5. S.R. Lockhart, D. Wagner, N. Iqbal, P.G. Pappas, D.R. Andes, and C.A. Kauffman et al. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006 J Clin Microbiol 49 2011 2404 2410
6. J.L. Vincent, J. Rello, J. Marshall, E. Silva, A. Anzueto, and C.D. Martin et al. International study of the prevalence and outcomes of infection in intensive care units JAMA 302 2009 2323 2329
7. M.C. Arendrup, E. Dzajic, R.H. Jensen, H.K. Johansen, P. Kjaeldgaard, and J.D. Knudsen et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme Clin Microbiol Infect 19 2013 E343 E353
8. M.P. Wille, T. Guimarães, G.H.C. Furtado, and A.L. Colombo Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil Mem Inst Oswaldo Cruz 108 2013 288 292
9. M.A. Pfaller, D.J. Diekema, D.L. Gibbs, V.A. Newell, J.F. Meis, and I.M. Gould et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing J Clin Microbiol 45 2007 1735 1745 (Pubitemid 46933900)
10. A. Lignell, E. Löwdin, O. Cars, D. Sanglard, and J. Sjölin Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone Antimicrob Agents Chemother 55 2011 1629 1637
11. G. Ramage, R. Rajendran, L. Sherry, and C. Williams Fungal biofilm resistance Int J Microbiol 2012 2012 528521
12. O. Marchetti, P. Moreillon, J.M. Entenza, J. Vouillamoz, M.P. Glauser, and J. Bille et al. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes Antimicrob Agents Chemother 47 2003 1565 1570 (Pubitemid 36548538)
13. A. Tragiannidis, C. Tsoulas, K. Kerl, and A.H. Groll Invasive candidiasis: update on current pharmacotherapy options and future perspectives Expert Opin Pharmacother 14 2013 1515 1528
14. J.A. Karlowsky, D.J. Hoban, G.G. Zhanel, and B.P. Goldstein In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species Int J Antimicrob Agents 27 2006 174 177 (Pubitemid 43138853)
15. V. Chaturvedi, R. Ramani, D. Andes, D.J. Diekema, M.A. Pfaller, and M.A. Ghannoum et al. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis Antimicrob Agents Chemother 55 2011 1543 1548
16. B. Hwang, J. Cho, Hwang I.-s, H.-G. Jin, E.-R. Woo, and D.G. Lee Antifungal activity of lariciresinol derived from Sambucus williamsii and their membrane-active mechanisms in Candida albicans Biochem Biophys Res Commun 410 2011 489 493
17. A. Ahmad, A. Khan, N. Manzoor, and L.A. Khan Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida Microb Pathog 48 2010 35 41
18. A. Ahmad, A. Khan, and N. Manzoor Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole Eur J Pharm Sci 48 2013 80 86
19. S. Huang, Y.Y. Cao, B.D. Dai, X.R. Sun, Z.Y. Zhu, and Y.B. Cao et al. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole Biol Pharm Bull 31 2008 2234 2236
20. M.H. Miceli, S.M. Bernardo, and S.A. Lee In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms Int J Antimicrob Agents 34 2009 326 332
21. M.S.A. Khan, and I. Ahmad Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms J Antimicrob Chemother 67 2011 618 621
22. M.A.S. Alem, and L.J. Douglas Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans Antimicrob Agents Chemother 48 2003 41 47 (Pubitemid 38040174)
23. L.E. Cowen, S.D. Singh, J.R. Köhler, C. Collins, A.K. Zaas, and W.A. Schell et al. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease Proc Natl Acad Sci U S A 106 2009 2818 2823
24. W.J. Steinbach, J.L. Reedy, R.A. Cramer Jr, J.R. Perfect, and J. Heitman Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections Nat Rev Microbiol 5 2007 418 430 (Pubitemid 46780079)
25. A. Fiori, and P. Van Dijck Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis Antimicrob Agents Chemother 56 2012 3785 3796
26. S. Gamarra, E.M.F. Rocha, Y.Q. Zhang, S. Park, R. Rao, and D.S. Perlin Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans Antimicrob Agents Chemother 54 2010 1753 1761
27. T. Xu, Q. Feng, M.R. Jacob, B. Avula, M.M. Mask, and S.R. Baerson et al. The marine sponge-derived polyketide endoperoxide plakortide F acid mediates its antifungal activity by interfering with calcium homeostasis Antimicrob Agents Chemother 55 2011 1611 1621
28. T. Kobayashi, H. Kakeya, T. Miyazaki, K. Izumikawa, K. Yanagihara, and H. Ohno et al. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis Jpn J Infect Dis 64 2011 292 296
29. J.M. Schierholz, G. Pulverer, A. Bach, and Z. Wachol-Drebeck In vitro activity of rifampin-minocyclin coating to Candida albicans Crit Care Med 27 1999 1691 1693 (Pubitemid 29406986)
30. M. Wilson, B. O'Connor, and H.N. Newman Isolation and identification of bacteria from subgingival plaque with low susceptibility to minocycline J Antimicrob Chemother 28 1991 71 78
31. L.F. de Oliveira, A.O. Jorge, and S.S. Dos Santos In vitro minocycline activity on superinfecting microorganisms isolated from chronic periodontitis patients Braz Oral Res 20 2006 202 206 (Pubitemid 44613633)
32. W. Shi, Z. Chen, X. Chen, L. Cao, P. Liu, and S. Sun The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents FEMS Yeast Res 10 2010 885 893
33. Y. Gao, C. Zhang, C. Lu, P. Liu, Y. Li, and H. Li et al. Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers FEMS Yeast Res 13 2013 453 462
34. G.S. Baillie, and L.J. Douglas Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents J Antimicrob Chemother 46 2000 397 403
35. P. Uppuluri, J. Nett, J. Heitman, and D. Andes Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms Antimicrob Agents Chemother 52 2008 1127 1132 (Pubitemid 351358397)
36. R.B. Shinde, N.M. Chauhan, J.S. Raut, and S.M. Karuppayil Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine Ann Clin Microbiol Antimicrob 11 2012 27
37. L.A. Mermel, M. Allon, E. Bouza, D.E. Craven, P. Flynn, and N.P. O'Grady et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America Clin Infect Dis 49 2009 1 45
38. K.S. Ko, J.Y. Lee, J.H. Song, and K.R. Peck In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms J Korean Med Sci 25 2010 1722 1726
39. T. Stergiopoulou, J. Meletiadis, T. Sein, P. Papaioannidou, I. Tsiouris, and E. Roilides et al. Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus J Antimicrob Chemother 63 2009 343 348
40. T. Stergiopoulou, J. Meletiadis, T. Sein, P. Papaioannidou, I. Tsiouris, and E. Roilides et al. Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus Antimicrob Agents Chemother 52 2008 2196 2204 (Pubitemid 351758559)
41. A.M. Sugar, X.P. Liu, and R.J. Chen Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs Antimicrob Agents Chemother 41 1997 2518 2521 (Pubitemid 27467566)
42. R. Nakajima, A. Kitamura, K. Someya, M. Tanaka, and K. Sato In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi Antimicrob Agents Chemother 39 1995 1517 1521
43. E. Sasaki, S. Maesaki, Y. Miyazaki, K. Yanagihara, K. Tomono, and T. Tashiro et al. Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans J Infect Chemother 6 2000 151 154
44. F. Van Bambeke, J.M. Michot, J. Van Eldere, and P.M. Tulkens Quinolones in 2005: an update Clin Microbiol Infect 11 2005 256 280 (Pubitemid 40443832)
45. L.L. Shen, J. Baranowski, J. Fostel, D.A. Montgomery, and P.A. Lartey DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs Antimicrob Agents Chemother 36 1992 2778 2784
46. D. Sanglard, F. Ischer, O. Marchetti, J. Entenza, and J. Bille Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence Mol Microbiol 48 2003 959 976 (Pubitemid 36628262)
47. Y.L. Chen, A. Brand, E.L. Morrison, F.G. Silao, U.G. Bigol, and F.F. Malbas Jr et al. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis Eukaryot Cell 10 2011 803 819
48. J. Zhang, F.G. Silao, U.G. Bigol, A.A. Bungay, M.G. Nicolas, and J. Heitman et al. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae PLOS ONE 7 2012 e44192
49. J.R. Blankenship, F.L. Wormley, M.K. Boyce, W.A. Schell, S.G. Filler, and J.R. Perfect et al. Calcineurin is essential for Candida albicans survival in serum and virulence Eukaryot Cell 2 2003 422 430 (Pubitemid 36774691)
50. Y. Jia, R.-J. Tang, L. Wang, X. Zhang, Y. Wang, and X.-M. Jia et al. Calcium-activated-calcineurin reduces the in vitro and in vivo sensitivity of fluconazole to Candida albicans via Rta2p PLOS ONE 7 2012 e48369
51. X.M. Jia, Y. Wang, Y. Jia, P.H. Gao, Y.G. Xu, and L. Wang et al. RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans Cell Mol Life Sci 66 2009 122 134
52. A. Odom, M. Del Poeta, J. Perfect, and J. Heitman The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein Antimicrob Agents Chemother 41 1997 156 161 (Pubitemid 26428148)
53. M.C. Cruz, M. Del Poeta, P. Wang, R. Wenger, G. Zenke, and V.F. Quesniaux et al. Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin Antimicrob Agents Chemother 44 2000 143 149 (Pubitemid 30010685)
54. M.C. Cruz, A.L. Goldstein, J.R. Blankenship, M. Del Poeta, D. Davis, and M.E. Cardenas et al. Calcineurin is essential for survival during membrane stress in Candida albicans EMBO J 21 2002 546 559 (Pubitemid 34174036)
55. S. Sun, Y. Li, Q. Guo, C. Shi, J. Yu, and L. Ma In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods Antimicrob Agents Chemother 52 2008 409 417 (Pubitemid 351170807)
56. O. Marchetti, P. Moreillon, M.P. Glauser, J. Bille, and D. Sanglard Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans Antimicrob Agents Chemother 44 2000 2373 2381 (Pubitemid 30650882)
57. N. Robbins, P. Uppuluri, J. Nett, R. Rajendran, G. Ramage, and J.L. Lopez-Ribot et al. Hsp90 governs dispersion and drug resistance of fungal biofilms PLoS Pathog 7 2011 e1002257
58. S.L. LaFayette, C. Collins, A.K. Zaas, W.A. Schell, M. Betancourt-Quiroz, and A.A. Gunatilaka et al. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90 PLoS Pathog 6 2010 e1001069
59. S.D. Singh, N. Robbins, A.K. Zaas, W.A. Schell, J.R. Perfect, and L.E. Cowen Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin PLoS Pathog 5 2009 e1000532
60. L.E. Cowen Hsp90 orchestrates stress response signaling governing fungal drug resistance PLoS Pathog 5 2009 e1000471
61. M. Becherelli, J. Tao, and N.S. Ryder Involvement of heat shock proteins in Candida albicans biofilm formation J Mol Microbiol Biotechnol 23 2013 396 400
62. B. Dai, Y. Wang, D. Li, Y. Xu, R. Liang, and L. Zhao et al. Hsp90 is involved in apoptosis of Candida albicans by regulating the calcineurin-caspase apoptotic pathway PLOS ONE 7 2012 e45109
63. J.A. Hill, R. Ammar, D. Torti, C. Nislow, and L.E. Cowen Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations PLoS Genet 9 2013 e1003390
64. J. Cui, J.A. Kaandorp, P.M. Sloot, C.M. Lloyd, and M.V. Filatov Calcium homeostasis and signaling in yeast cells and cardiac myocytes FEMS Yeast Res 9 2009 1137 1147
65. W.E. Courchesne, and S. Ozturk Amiodarone induces a caffeine-inhibited, MID1-dependent rise in free cytoplasmic calcium in Saccharomyces cerevisiae Mol Microbiol 47 2003 223 234 (Pubitemid 36051336)
66. NN5353 activates the cell wall integrity pathway and perturbs calcium homeostasis BMC Microbiol 11 2011 209
67. A. Lupetti, C.P. Brouwer, H.E. Dogterom-Ballering, S. Senesi, M. Campa, and J.T. Van Dissel et al. Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin J Antimicrob Chemother 54 2004 603 608 (Pubitemid 39263900)
68. S.S. Gupta, V.K. Ton, V. Beaudry, S. Rulli, K. Cunningham, and R. Rao Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis J Biol Chem 278 2003 28831 28839 (Pubitemid 36935793)
69. L. Maresova, S. Muend, Y.Q. Zhang, H. Sychrova, and R. Rao Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone J Biol Chem 284 2008 2795 2802
70. S. Muend, and R. Rao Fungicidal activity of amiodarone is tightly coupled to calcium influx FEMS Yeast Res 8 2008 425 431 (Pubitemid 351579654)
71. Q. Guo, S. Sun, J. Yu, Y. Li, and L. Cao Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods J Med Microbiol 57 2008 457 462 (Pubitemid 351537020)
72. W.E. Courchesne Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone J Pharmacol Exp Ther 300 2002 195 199 (Pubitemid 34028527)
73. A. Rao, Y. Zhang, S. Muend, and R. Rao Mechanism of antifungal activity of terpenoid phenols resembles calcium stress and inhibition of the TOR pathway Antimicrob Agents Chemother 54 2010 5062 5069
74. H. Quan, Y.Y. Cao, Z. Xu, J.X. Zhao, P.H. Gao, and X.F. Qin et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole Antimicrob Agents Chemother 50 2006 1096 1099 (Pubitemid 43327820)
75. Z. Yan, H. Hua, Y. Xu, and L.P. Samaranayake Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral Candida species and the synergy with fluconazole against azole-resistant Candida albicans Evid Based Complement Alternat Med 2012 2012 106583
76. N. Guo, G. Ling, X. Liang, J. Jin, J. Fan, and J. Qiu et al. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans Mycoses 54 2011 e400 e406
77. A. Ahmad, A. Khan, L.A. Khan, and N. Manzoor In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates J Med Microbiol 59 2010 1178 1184
78. N. Chami, S. Bennis, F. Chami, A. Aboussekhra, and A. Remmal Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo Oral Microbiol Immunol 20 2005 106 111 (Pubitemid 40364735)
79. P.C. Braga, M.D. Sasso, M. Culici, and M. Alfieri Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans Fitoterapia 78 2007 396 400 (Pubitemid 47284675)
80. H. Miao, L. Zhao, C. Li, Q. Shang, H. Lu, and Z. Fu et al. Inhibitory effect of shikonin on Candida albicans growth Biol Pharm Bull 35 2012 1956 1963
81. A.M. Aerts, L. Bammens, G. Govaert, D. Carmona-Gutierrez, F. Madeo, and B.P. Cammue et al. The antifungal plant defensin HsAFP1 from Heuchera sanguinea induces apoptosis in Candida albicans Front Microbiol 2 2011 47
82. M.A. Alem, and L.J. Douglas Prostaglandin production during growth of Candida albicans biofilms J Med Microbiol 54 2005 1001 1005 (Pubitemid 41566768)
83. 2 production by Candida albicans and Candida dubliniensis biofilms Med Microbiol Immunol 200 2010 23 28
84. 2-dependent mechanism Folia Microbiol (Praha) 56 2011 349 352
85. R. Arai, T. Sugita, and A. Nishikawa Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans Mycoses 48 2005 38 41 (Pubitemid 40255399)
86. E. Ricardo, S. Costa-de-Oliveira, A.S. Dias, J. Guerra, A.G. Rodrigues, and C. Pina-Vaz Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes FEMS Yeast Res 9 2009 618 625
87. Y. Kaneko, H. Fukazawa, H. Ohno, and Y. Miyazaki Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans J Infect Chemother 19 2013 1141 1145
88. M.P. Venkatesh, and L. Rong Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis J Med Microbiol 57 2008 1113 1121
89. T. Lehrnbecher, S. Schmidt, L. Tramsen, and T. Klingebiel Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients Front Oncol 3 2013 17
90. J.H. Lee, E.C. Jang, and Y. Han Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis Arch Pharm Res 34 2011 399 405